Koon M. Foo

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.

Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.

Journal: Scientific reports

Published: July 22, 2023

Anthracycline-Free Protocol for Favorable-Risk Childhood ALL: A Noninferiority Comparison Between Malaysia-Singapore ALL 2003 and ALL 2010 Studies.

Anthracycline-Free Protocol for Favorable-Risk Childhood ALL: A Noninferiority Comparison Between Malaysia-Singapore ALL 2003 and ALL 2010 Studies.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 05, 2023

Development of a pharmacy educational environment questionnaire.

Development of a pharmacy educational environment questionnaire.

Journal: Currents in pharmacy teaching & learning

Published: October 19, 2022

Cognitive impairment in adolescent and young adult cancer patients: Pre-treatment findings of a longitudinal study.

Cognitive impairment in adolescent and young adult cancer patients: Pre-treatment findings of a longitudinal study.

Journal: Cancer medicine

Published: September 02, 2022

Life-threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia-Singapore 2003 and 2010 clinical trials: A risk prediction model.

Life-threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia-Singapore 2003 and 2010 clinical trials: A risk prediction model.

Journal: Asia-Pacific journal of clinical oncology

Published: June 09, 2021

Successful toxicity reduction during delayed intensification in the non-high-risk arm of Malaysia-Singapore Acute Lymphoblastic Leukaemia 2010 study.

Successful toxicity reduction during delayed intensification in the non-high-risk arm of Malaysia-Singapore Acute Lymphoblastic Leukaemia 2010 study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 15, 2020

An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study.

An Evaluation of DNA Methyltransferase 1 (DNMT1) Single Nucleotide Polymorphisms and Chemotherapy-Associated Cognitive Impairment: A Prospective, Longitudinal Study.

Journal: Scientific reports

Published: July 04, 2019

Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study.

Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort study.

Journal: Journal of cellular and molecular medicine

Published: December 02, 2018

Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.

Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.

Journal: Molecular neurobiology

Published: September 21, 2018

Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.

Association of mitochondrial DNA content in peripheral blood with cancer-related fatigue and chemotherapy-related cognitive impairment in early-stage breast cancer patients: a prospective cohort study.

Journal: Breast cancer research and treatment

Published: October 09, 2017

Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.

Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors.

Journal: Psycho-oncology

Published: August 02, 2017

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.

Journal: Neuro-oncology

Published: May 08, 2015

Showing 1-12 of 13

Last Updated: 09/26/2026